| Financial Year |
March 31 2023 |
| Monetary Funds |
4,424,012,025.80 |
| Held-for-trading Financial Assets |
171,784,793.37 |
| Notes Receivable |
609,132.90 |
| Accounts Receivable |
625,013,447.85 |
| Advances to Suppliers |
44,942,302.36 |
| Other Receivables |
48,523,630.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,317,323.69 |
| Dividend Receivable |
-- |
| Inventories |
373,291,678.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,298,633.98 |
| Total Current Assets |
5,738,475,644.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
314,944,282.72 |
| Investment Properties |
34,864,783.67 |
| Fixed Assetes |
520,998,439.63 |
| Under-construction Projects |
114,146,325.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
735,502,001.38 |
| R&D expenses |
701,767,145.63 |
| Goodwill |
1,192,212,473.85 |
| Long-Term Deferred and Prepaid Expenses |
858,823.23 |
| Deferred Income Tax Assets |
110,684,624.62 |
| Other Non-Current Assets |
35,595,592.73 |
| Sub-Total of Non-Current Assets |
3,814,710,249.21 |
| Total Assets |
9,553,185,893.86 |
| Short-Term Loans |
395,063.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,791,723.00 |
| Accounts Payable |
247,264,516.36 |
| Accounts Received In Advance |
-4,007,210.51 |
| Employee Compensation Payable |
93,713,557.50 |
| Taxes Payable |
191,845,564.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
274,238,468.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,382,937.57 |
| Other Current Liabilities |
38,030,519.13 |
| Sub-Total of Current Liabilities |
1,401,639,504.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
83,335.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,995,866.82 |
| Deferred Income Tax Liabilities |
18,867,834.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,223,953.11 |
| Total Liabilities |
1,470,863,457.35 |
| Paid-In Capital(Or Share Stock) |
2,099,379,878.00 |
| Capital Surplus |
3,381,643,039.64 |
| Surplus Reserve |
121,660,662.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,558,706,989.48 |
| Minority Stockholder's Interest |
663,836,647.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,418,485,788.94 |
| Owner's Equity（Stockholder's Equity） |
8,082,322,436.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,553,185,893.86 |
